About sorafenib in castration-resistant prostate cancer

  • Chi, K. N.
  • Seymour, L.

  • 1Department of Clinical Trials, University of British Columbia, Vancouver, Canada

    2National Cancer Institute of Canada–Clinical Trials Group, Queen's University, Kingston, Canada

*E-mail: [email protected]

Annals of Oncology 19(10):p 1813-1814, October 2008.
Copyright © 2008 The European Society for Medical Oncology